Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm, today announced a research partnership with the John A.
Two cannabinoids, one burning question: which one will rock your world? If you’ve spent any time scrolling through Reddit threads or talking to your cannabis-loving friends, you’ve probably heard some ...